Operating

Change in Other Assets

Alnylam Pharmaceuticals Change in Other Assets decreased by 91.1% to $6.32M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 80.7%, from $32.77M to $6.32M.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025

How to read this metric

Large swings are usually related to the timing of prepayments for services or long-term supply agreements.

Detailed definition

This captures the net change in miscellaneous operating assets not classified as receivables or inventory, such as prepa...

Peer comparison

This is typically a smaller component of cash flow for most large-cap technology firms unless they are securing long-term supply capacity.

Metric ID: change_in_other_assets

Historical Data

17 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$16.97M$18.14M$29.85M$21.31M-$3.97M$1.24M$27.87M$3.32M$75.46M-$61.69M$8.28M-$25.28M$32.77M-$6.78M$20.74M$70.99M$6.32M
QoQ Change+6.9%+64.5%-28.6%-118.6%+131.1%>999%-88.1%>999%-181.7%+113.4%-405.4%+229.6%-120.7%+406.1%+242.3%-91.1%
YoY Change+25.6%-121.9%-95.9%+30.8%+183.7%>999%-321.3%+149.5%-56.6%+89.0%+150.6%+380.8%-80.7%
Range-$61.69M$75.46M
CAGR-21.9%
Avg YoY Growth+488.0%
Median YoY Growth+30.8%

Change in Other Assets at Other Companies

Frequently Asked Questions

What is Alnylam Pharmaceuticals's change in other assets?
Alnylam Pharmaceuticals (ALNY) reported change in other assets of $6.32M in Q1 2026.
How has Alnylam Pharmaceuticals's change in other assets changed year-over-year?
Alnylam Pharmaceuticals's change in other assets decreased by 80.7% year-over-year, from $32.77M to $6.32M.
What does change in other assets mean?
The change in various other business assets like prepayments or miscellaneous deposits.